3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
6
Esophageal Neoplasms
4
Gastrointestinal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Adenocarcinoma
2
Solid Tumor
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Neoplasms, Unknown Primary
1
Nasopharyngeal Carcinoma
1
Locally Advanced Gastric Adenocarcinoma
1
Hand-Foot Syndrome
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Celecoxib
2
Capecitabine
2
tegafur-gimeracil-oteracil
1
mecobalamin
1
liposomal doxorubicin
1
Urea
1
Tobacco Use Cessation Devices
1
Standard of Care
1
S 1 (combination)
1
Radiotherapy
1
Pyridoxine
1
Pharmacokinetics
1
Medicine, Chinese Traditional
1
Low-Level Light Therapy
1
Diclofenac
1
Brimonidine Tartrate
1
Blood Specimen Collection
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hand-Foot Syndrome
×
tegafur-gimeracil-oteracil
×
Clear all
NCT01918852
2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3
Completed
161 enrolled